422 related articles for article (PubMed ID: 22959962)
21. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
22. Human induced pluripotent stem cells--from mechanisms to clinical applications.
Drews K; Jozefczuk J; Prigione A; Adjaye J
J Mol Med (Berl); 2012 Jul; 90(7):735-45. PubMed ID: 22643868
[TBL] [Abstract][Full Text] [Related]
23. Small-molecule-mediated reprogramming: a silver lining for regenerative medicine.
Kim Y; Jeong J; Choi D
Exp Mol Med; 2020 Feb; 52(2):213-226. PubMed ID: 32080339
[TBL] [Abstract][Full Text] [Related]
24. A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs.
Neganova I; Chichagova V; Armstrong L; Lako M
Sci Rep; 2017 Feb; 7():41693. PubMed ID: 28155868
[TBL] [Abstract][Full Text] [Related]
25. Strategies to generate induced pluripotent stem cells.
Hayes M; Zavazava N
Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
[TBL] [Abstract][Full Text] [Related]
26. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming.
Hu X; Zhang L; Mao SQ; Li Z; Chen J; Zhang RR; Wu HP; Gao J; Guo F; Liu W; Xu GF; Dai HQ; Shi YG; Li X; Hu B; Tang F; Pei D; Xu GL
Cell Stem Cell; 2014 Apr; 14(4):512-22. PubMed ID: 24529596
[TBL] [Abstract][Full Text] [Related]
27. Protein Kinase A Signaling Is Inhibitory for Reprogramming into Pluripotent Stem Cells.
Kim JS; Hong YJ; Choi HW; Choi S; Do JT
Stem Cells Dev; 2016 Mar; 25(5):378-85. PubMed ID: 26728702
[TBL] [Abstract][Full Text] [Related]
28. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
29. Chemical compound-based direct reprogramming for future clinical applications.
Takeda Y; Harada Y; Yoshikawa T; Dai P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29739872
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
31. iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa G; Adami R; Bottai D
Cells; 2021 Jun; 10(6):. PubMed ID: 34208270
[TBL] [Abstract][Full Text] [Related]
32. The genomic stability of induced pluripotent stem cells.
Chen Z; Zhao T; Xu Y
Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751
[TBL] [Abstract][Full Text] [Related]
33. A reprogrammable mouse strain from gene-targeted embryonic stem cells.
Stadtfeld M; Maherali N; Borkent M; Hochedlinger K
Nat Methods; 2010 Jan; 7(1):53-5. PubMed ID: 20010832
[TBL] [Abstract][Full Text] [Related]
34. The aging signature: a hallmark of induced pluripotent stem cells?
Rohani L; Johnson AA; Arnold A; Stolzing A
Aging Cell; 2014 Feb; 13(1):2-7. PubMed ID: 24256351
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics of reprogramming to induced pluripotency.
Papp B; Plath K
Cell; 2013 Mar; 152(6):1324-43. PubMed ID: 23498940
[TBL] [Abstract][Full Text] [Related]
37. Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.
Ye J; Ge J; Zhang X; Cheng L; Zhang Z; He S; Wang Y; Lin H; Yang W; Liu J; Zhao Y; Deng H
Cell Res; 2016 Jan; 26(1):34-45. PubMed ID: 26704449
[TBL] [Abstract][Full Text] [Related]
38. Transitions between epithelial and mesenchymal states during cell fate conversions.
Li X; Pei D; Zheng H
Protein Cell; 2014; 5(8):580-91. PubMed ID: 24805308
[TBL] [Abstract][Full Text] [Related]
39. Resetting epigenetic signatures to induce somatic cell reprogramming.
Lluis F; Cosma MP
Cell Mol Life Sci; 2013 Apr; 70(8):1413-24. PubMed ID: 22932957
[TBL] [Abstract][Full Text] [Related]
40. A Revolution in Reprogramming: Small Molecules.
Zhou J; Sun J
Curr Mol Med; 2019; 19(2):77-90. PubMed ID: 30914022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
